Analysis
3 Key Questions On Trump's Pharma Tariffs
By Dylan Moroses
President Donald Trump recently announced 100% tariffs on certain imported pharmaceutical products, with opportunities for drug companies to lower their tariff rates to zero, but questions remain about the requirements for preferential treatment and abilities to administer the regime. Here, Law360 examines three open questions surrounding pharmaceutical tariffs' implementation.
1 document attached |
Read full article »
| Save to favorites »
POLICY & REGULATION
ENFORCEMENT & COMPLIANCE
LITIGATION
Roundup
UK Litigation Roundup: Here's What You Missed In London
By Laura Stewart Liberty
The past week in London has seen Aston Martin file an appeal in a row with Chinese carmaker Geely over its winged logo for London black cabs, Ineos sue Ben Ainslie's America's Cup team for a £180 million ($244 million) boat, White & Case face a claim from two energy storage companies, and a golf tour company bring a claim against Saudi Arabia's sovereign wealth fund after the fund invested in its rival.
Read full article »
| Save to favorites »
Allstate Says Fla. Surgery Centers Padded Bills For Care
By Carolina Bolado
Seven ambulatory surgery centers, a pain clinic and an anesthesia practice that are all run by Surgery Partners conducted "extraordinarily aggressive treatment" on patients involved in minor car crashes to inflate the bills submitted to Allstate, the insurer told a Florida federal court Friday, alleging it paid millions for unnecessary treatment.
Complaint attached |
Read full article »
| Save to favorites »
AI Health Co. Illegally Shared Genetic Data, Patients Say
By Celeste Bott
A healthcare company powered by artificial intelligence violated Illinois' genetic privacy law and other consumer protection laws by compelling a genetic testing business it acquired to disclose patients' genetic information, which it then shared through data agreements with pharmaceutical giants such as Eli Lilly and AbbVie, a lawsuit in Illinois federal court says.
Complaint attached |
Read full article »
| Save to favorites »
DEALS
BANKRUPTCY
PEOPLE
EXPERT ANALYSIS
LEGAL INDUSTRY
Roundup
GC Cheat Sheet: The Hottest Corporate News Of The Week
By Michele Gorman
New data found that some companies are being wary during the 2026 proxy season by negotiating deals behind closed doors rather than allowing shareholders to vote on issues. In the meantime, a report showed that the higher annual rate growth for outside counsel fees that began in 2022 has become the new normal. These are some of the stories in corporate legal news you may have missed in the past week.
Read full article »
| Save to favorites »
|